Clinical Trial Update: A Prospective, Phase IV, Surveillance Registry Study to Evaluate the Safety of DEFINITY® in Clinical Practice [Phase 4]

View source ↗

Summary

A Phase IV surveillance registry assessing the safety of DEFINITY® in clinical practice has been completed with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease

Drugs mentioned

• DEFINITY (perflutren lipid microspheres)

Snippet

Sponsor: Lantheus Medical Imaging | Conditions: Cardiovascular Disease | Phase 4 | Status: COMPLETED | Results posted: 2011-01-14